Business Context and Reporting Period
Company: Church & Dwight Co., Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2005
Business Overview: The Company operates in three segments: Consumer Domestic (household and personal care), Consumer International (primarily personal care), and Specialty Products Division (SPD). The reporting period includes the full impact of the Armkel acquisition completed in May 2004.
Key Financial Metrics
| Metric | Three Months Ended Sept 30, 2005 | Nine Months Ended Sept 30, 2005 |
|---|---|---|
| Net Sales | $442.7 million | $1,305.2 million |
| Gross Profit | $167.5 million | $496.7 million |
| Gross Margin | 37.8% | 38.1% |
| Operating Income | $53.9 million | $180.9 million |
| Net Income | $34.6 million | $106.7 million |
| Diluted EPS | $0.51 | $1.58 |
| Cash from Operations (9mo) | $131.2 million | |
| Total Debt (Sept 30, 2005) | $760.9 million | |
| Cash and Equivalents | $159.8 million |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 5.3% in the quarter and 23.5% for the nine-month period compared to 2004. The nine-month increase was driven primarily by the inclusion of Armkel sales for five months ($208.1 million) and favorable foreign exchange rates.
- Margin Compression: Gross margin declined to 37.8% in the quarter (from 38.2% in 2004) due to sharp price increases in oil-based raw materials, packaging, and energy costs, partially offset by pricing actions and cost reduction programs.
- Profitability: Net income rose 26.3% in the quarter and 38.8% for the nine months. However, results were impacted by an $8.3 million charge related to the "Andes litigation" verdict recorded in SG&A expenses.
- Debt Reduction: Total debt decreased from $858.7 million at year-end 2004 to $760.9 million, driven by $100 million in voluntary bank debt payments and the redemption of $6.4 million in 9.5% Senior Subordinated Notes.
Outlook, Risks, and Unusual Items
- Commodity Price Impact: Management expects higher commodity prices (oil, chemicals, energy) resulting from Hurricanes Katrina and Rita to adversely affect fourth-quarter earnings by $0.06 to $0.07 per share.
- Legal Contingency: A $15.0 million jury verdict was rendered against the Company in the "Andes litigation" regarding exclusive distribution rights in Mexico. The Company recorded an $8.3 million charge and intends to appeal vigorously.
- Regulatory Risk: The FDA is reviewing the use of nonoxynol-9 (N-9) in condoms. While the Company has implemented interim labeling changes, future restrictions could impact financial results.
- Subsequent Acquisitions: On October 31, 2005, the Company acquired the SpinBrush toothbrush business from P&G for $75.0 million cash, with potential additional payments of up to $30.0 million based on performance.
- Plant Closure: The Company announced the closure of an international consumer packaged goods plant, estimating closure costs between $5.0 million and $7.0 million.
Investor Verification Checklist
- Andes Litigation Appeal: Monitor the status of the appeal regarding the $15.0 million verdict and potential for additional financial exposure.
- Commodity Hedging: Verify the effectiveness of cost-reduction programs and pricing strategies in mitigating the impact of rising oil and raw material costs on Q4 margins.
- SpinBrush Integration: Track the performance of the newly acquired SpinBrush business to determine if it meets the thresholds for the $30.0 million contingent payment.
- Debt Covenants: Confirm continued compliance with the leverage ratio (2.56x) and interest coverage ratio (6.6x) under the primary credit facility.
- FDA Guidance: Watch for final FDA rulings on N-9 labeling requirements and their potential impact on the Trojan brand sales.